Intro Pullout Text Widget

Drug and Therapeutics Bulletin

(DTB) covers practical, independent and evidence-based information on drugs, medication and prescribing.

Drug and Therapeutics Bulletin (DTB) publishes independent evaluations and practical advice on individual treatments and the overall management of disease. DTB summarises the best available evidence to enable doctors, pharmacists and other healthcare professionals to make informed and unbiased choices to help patients get the best care. DTB is wholly independent of the pharmaceutical industry, government and regulatory authorities and is also free of advertising and other forms of commercial sponsorship.

DTB publishes regular podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Apple, Google, Stitcher and Spotify.

Current Issue

60 years of practical, independent and trusted advice

Editor-in-Chief, Dr James Cave, talks about DTB past, present and future

31 March, 2022

We're celebrating 60 years since the first edition of the Drug and Therapeutics Bulletin (DTB) was published, in April 1962.
In this video, James Cave (Editor-in-Chief) talks about DTB's early days and the pioneering role DTB played in publishing independent evidence-based information on medicines.
Over the last six decades, DTB has broadened its content to meet the needs of its readers. In this conversation with the Deputy Editor, David Phizackerley, James talks about the different types of articles and highlights the ongoing importance of providing independent information on drugs and therapeutics to enable healthcare professionals to make informed and unbiased choices to help patients get the best care. Over the next few months, we will be publishing a series of special articles and interviews with a focus on the importance of drug bulletins. We are also offering an exclusive 25% discount for new subscribers - find out more now (link).